Building an RNA-Based Toggle Switch Using Inhibitory RNA Aptamers

被引:7
|
作者
Climent-Catala, Alicia [1 ,2 ]
Ouldridge, Thomas E. [1 ,3 ]
Stan, Guy-Bart, V [1 ,3 ]
Bae, Wooli [1 ,3 ,4 ]
机构
[1] Imperial Coll, Ctr Synthet Biol, London SW7 2AZ, England
[2] Imperial Coll London, Dept Chem, London SW7 2AZ, England
[3] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England
[4] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England
来源
ACS SYNTHETIC BIOLOGY | 2022年 / 11卷 / 02期
基金
英国工程与自然科学研究理事会;
关键词
RNA circuit; toggle switch; in vitro transcription; RNA aptamer; RNA polymerases; RNase; GENE-EXPRESSION; EMERGING FIELD; FLUORESCENCE; FLUOROPHORE; SELECTION; CIRCUITS;
D O I
10.1021/acssynbio.1c00580
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic RNA systems offer unique advantages such as faster response, increased specificity, and programmability compared to conventional protein-based networks. Here, we demonstrate an in vitro RNA-based toggle switch using RNA aptamers capable of inhibiting the transcriptional activity of T7 or SP6 RNA polymerases. The activities of both polymerases are monitored simultaneously by using Broccoli and malachite green light up aptamer systems. In our toggle switch, a T7 promoter drives the expression of SP6 inhibitory aptamers, and an SP6 promoter expresses T7 inhibitory aptamers. We show that the two distinct states originating from the mutual inhibition of aptamers can be toggled by adding DNA sequences to sequester the RNA inhibitory aptamers. Finally, we assessed our RNA based toggle switch in degrading conditions by introducing controlled degradation of RNAs using a mix of RNases. Our results demonstrate that the RNA-based toggle switch could be used as a control element for nucleic acid networks in synthetic biology applications.
引用
收藏
页码:562 / 569
页数:8
相关论文
共 50 条
  • [1] Intracellular delivery of RNA-based therapeutics using aptamers
    Thiel, Kristina W.
    Giangrande, Paloma H.
    THERAPEUTIC DELIVERY, 2010, 1 (06) : 849 - 861
  • [2] Aptamers in RNA-based switches of gene expression
    Spoering, Maike
    Finke, Monika
    Hartig, Joerg S.
    CURRENT OPINION IN BIOTECHNOLOGY, 2020, 63 : 34 - 40
  • [3] RNA interference in vivo:: Toward synthetic small inhibitory RNA-based therapeutics
    De Fougerolles, A
    Manoharan, M
    Meyers, R
    Vornlocher, HP
    RNA INTERFERENCE, 2005, 392 : 278 - 296
  • [4] An RNA-Based Switch for Dialing Gene Therapy Up or Down
    Genetic Engineering and Biotechnology News, 2024, 44 (02): : 11
  • [5] Telomerase RNA-based aptamers restore defective myelopoiesis in congenital neutropenic syndromes
    Elena Martínez-Balsalobre
    Jesús García-Castillo
    Diana García-Moreno
    Elena Naranjo-Sánchez
    Miriam Fernández-Lajarín
    María A. Blasco
    Francisca Alcaraz-Pérez
    Victoriano Mulero
    María L. Cayuela
    Nature Communications, 14 (1)
  • [6] Telomerase RNA-based aptamers restore defective myelopoiesis in congenital neutropenic syndromes
    Martinez-Balsalobre, Elena
    Garcia-Castillo, Jesus
    Garcia-Moreno, Diana
    Naranjo-Sanchez, Elena
    Fernandez-Lajarin, Miriam
    Blasco, Maria A.
    Alcaraz-Perez, Francisca
    Mulero, Victoriano
    Cayuela, Maria L.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [7] An RNA-based transcription activator derived from an inhibitory aptamer
    Wang, Shengchun
    Shepard, Jason R. E.
    Shi, Hua
    NUCLEIC ACIDS RESEARCH, 2010, 38 (07) : 2378 - 2386
  • [8] RNA-based therapies
    不详
    NATURE BIOTECHNOLOGY, 2019, 37 (02) : 129 - 129
  • [9] RNA-based therapies
    Nature Biotechnology, 2023, 41 : 1071 - 1071
  • [10] RNA-based therapies
    不详
    NATURE BIOTECHNOLOGY, 2023, 41 (08) : 1071 - 1071